7 results on '"Chi, David"'
Search Results
2. Socioeconomic status and pediatric cochlear implant usage during COVID-19.
- Author
-
Awad DR, Tang AJ, Venskytis EJ, Levy R, Kitsko DJ, Shaffer AD, and Chi DH
- Subjects
- Humans, Child, Male, Infant, Child, Preschool, Infant, Newborn, Adolescent, Female, Social Class, Cochlear Implants, Speech Perception, COVID-19, Cochlear Implantation
- Abstract
Objective: COVID-19 (COVID) delayed access to speech and hearing services. The objective of this study was to identify interactions between socioeconomic status (SES) and cochlear implant (CI) usage during COVID., Methods: Consecutive pediatric patients (age 0-17) with CI and audiology visits between 2019 and 2022 at a tertiary care children's hospital were reviewed. Age, sex, race, insurance type, and proxy measures for SES using zip code were recorded. Hours spent with CI on and in different listening environments were compared between pre-COVID (1/1/2019-12/31/2019), COVID (4/1/2020-3/31/2021), and most recent (6/1/2021-5/31/2022) time periods., Results: Most patients were male (32/59, 54 % ears of 48 patients) and White, non-Hispanic (45/59, 76 %). Median age at implant was 2.0 years (range:0.6-12.2). There were no significant differences in hours spent with CI on during COVID compared with pre-COVID. However, children spent more time listening to louder noises (70-79 dB and ≥80 dB) recently compared with during COVID (p = 0.01 and 0.006, respectively). During COVID, children living in areas with greater educational attainment showed smaller reductions in total hours with CI on (β = 0.1, p = 0.02) and hours listening to speech in noise (β = 0.03, p = 0.005) compared with pre-COVID. In the most recent time period, children of minority race (β = -3.94 p = 0.008) and those who were older at implant (β = -0.630, p = 0.02) were more likely to experience reductions in total hours with CI on compared with during COVID., Conclusion: Interventions which mitigate barriers of implant use and promote rich listening home-environments for at risk populations should be implemented during challenging future social and environmental conditions., Competing Interests: Declaration of competing interest None., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Immediate Postmastectomy Implant-Based Breast Reconstruction: An Outpatient Procedure?
- Author
-
Keane AM, Keane GC, Skolnick GB, Chi D, Ebersole TD, Myckatyn TM, and Tenenbaum MM
- Subjects
- Humans, Female, Outpatients, Mastectomy adverse effects, Retrospective Studies, Postoperative Complications epidemiology, Postoperative Complications etiology, Breast Neoplasms etiology, COVID-19 epidemiology, COVID-19 complications, Mammaplasty methods, Breast Implants adverse effects
- Abstract
Background: Coronavirus disease of 2019 (COVID-19) poses unique challenges for breast reconstruction. At the authors' institution, COVID-19 postoperative protocols mandated patients undergoing immediate prosthetic breast reconstruction transition from 23-hour postoperative observation to same-day discharge. The authors sought to compare complications and hospital costs between these groups., Methods: A retrospective study of consecutive patients who underwent immediate prosthetic breast reconstruction from March of 2019 to April of 2021 at an academic hospital was performed. Before mid-March of 2020, patients were admitted postoperatively for observation; after mid-March of 2020, patients were discharged the same day. Postoperative complications at 48 hours, 30 days, and 90 days and hospital costs were compared., Results: There were 238 patients included (119 outpatient and 119 observation). Across all time points, total complications, major complications, categorical complications (wound healing, seroma, hematoma, infection, implant exposure), and reconstructive failures were low and not statistically different between groups. There were no differences in 30-day hospital readmission/reoperation rates (7.6% outpatient versus 9.2% observation; P = 0.640). No patient or surgical factors predicted major complication or hematoma by 48 hours or infection by 90 days. At 90 days, radiation history ( P = 0.002) and smoking ( P < 0.001) were significant predictors of major complications. Average patient care costs outside of surgery-specific costs were significantly lower for outpatients ($1509 versus $4045; P < 0.001)., Conclusions: Complications after immediate prosthetic breast reconstruction are low. Outpatient surgery is safe, harboring no increased risk of complications. Furthermore, outpatient care is more cost-effective. Therefore, surgeons should consider outpatient management of these patients to minimize COVID-19 exposure and reduce resource consumption, all while maintaining excellent surgical care., Clinical Question/level of Evidence: Therapeutic, III., (Copyright © 2023 by the American Society of Plastic Surgeons.)
- Published
- 2023
- Full Text
- View/download PDF
4. Aerosol and Droplet Risk of Common Otolaryngology Clinic Procedures.
- Author
-
Boorgu DSSK, Dharmarajan H, Sim ES, Goyal L, Freiser ME, Weinstock M, Whelan R, Corcoran TE, Jabbour N, Wang E, and Chi DH
- Subjects
- Cadaver, Humans, Outcome Assessment, Health Care, Personal Protective Equipment classification, Personal Protective Equipment virology, Research Design, Risk Assessment methods, SARS-CoV-2, Aerosols adverse effects, COVID-19 prevention & control, COVID-19 transmission, Disease Transmission, Infectious prevention & control, Endoscopy adverse effects, Endoscopy instrumentation, Endoscopy methods, Otolaryngology methods, Otolaryngology standards, Risk Adjustment methods, Suction adverse effects, Suction instrumentation, Suction methods
- Abstract
Objectives: Define aerosol and droplet risks associated with routine otolaryngology clinic procedures during the COVID-19 era., Methods: Clinical procedures were simulated in cadaveric heads whose oral and nasal cavities were coated with fluorescent tracer (vitamin B2) and breathing was manually simulated through retrograde intubation. A cascade impactor placed adjacent to the nares collected generated particles with aerodynamic diameters ≤14.1 µm. The 3D printed models and syringes were used to simulate middle and external ear suctioning as well as open suctioning, respectively. Provider's personal protective equipment (PPE) and procedural field contamination were also recorded for all trials using vitamin B2 fluorescent tracer., Results: The positive controls of nebulized vitamin B2 produced aerosol particles ≤3.30 µm and endonasal drilling of a 3D model generated particles ≤14.1 µm. As compared with positive controls, aerosols and small droplets with aerodynamic diameter ≤14.1 µm were not detected during rigid nasal endoscopy, flexible fiberoptic laryngoscopy, and rigid nasal suction of cadavers with simulated breathing. There was minimal to no field contamination in all 3 scenarios. Middle and external ear suctioning and open container suctioning did not result in any detectable droplet contamination. The clinic suction unit contained all fluorescent material without surrounding environmental contamination., Conclusion: While patients' coughing and sneezing may create a baseline risk for providers, this study demonstrates that nasal endoscopy, flexible laryngoscopy, and suctioning inherently do not pose an additional risk in terms of aerosol and small droplet generation. An overarching generalization cannot be made about endoscopy or suctioning being an aerosol generating procedure., Level of Evidence: 3.
- Published
- 2021
- Full Text
- View/download PDF
5. Droplet and Aerosol Generation With Mastoidectomy During the COVID-19 Pandemic: Assessment of Baseline Risk and Mitigation Measures With a High-performance Cascade Impactor.
- Author
-
Freiser ME, Dharmarajan H, Sri Kavya Boorgu DS, Sim ES, Corcoran TE, Jabbour N, and Chi DH
- Subjects
- Aerosols, COVID-19 transmission, Cadaver, Humans, Mastoidectomy instrumentation, Mastoidectomy methods, SARS-CoV-2, COVID-19 prevention & control, Mastoidectomy adverse effects
- Abstract
Hypothesis: Aerosols are generated during mastoidectomy and mitigation strategies may effectively reduce aerosol spread., Background: An objective understanding of aerosol generation and the effectiveness of mitigation strategies can inform interventions to reduce aerosol risk from mastoidectomy and other open surgeries involving drilling., Methods: Cadaveric and fluorescent three-dimensional printed temporal bone models were drilled under variable conditions and mitigation methods. Aerosol production was measured with a cascade impactor set to detect particle sizes under 14.1 μm. Field contamination was determined with examination under UV light., Results: Drilling of cadaveric bones and three-dimensional models resulted in strongly positive aerosol production, measuring positive in all eight impactor stages for the cadaver trials. This occurred regardless of using coarse or cutting burs, irrigation, a handheld suction, or an additional parked suction. The only mitigation factor that led to a completely negative aerosol result in all eight stages was placing an additional microscope drape to surround the field. Bone dust was scattered in all directions from the drill, including on the microscope, the surgeon, and visually suspended in the air for all but the drape trial., Conclusions: Aerosols are generated with drilling the mastoid. Using an additional microscope drape to cover the surgical field was an effective mitigation strategy to prevent fine aerosol dispersion while drilling., Competing Interests: The authors disclose no conflicts of interest., (Copyright © 2020, Otology & Neurotology, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
6. Novel Use of Vitamin B2 as a Fluorescent Tracer in Aerosol and Droplet Contamination Models in Otolaryngology.
- Author
-
Sim ES, Dharmarajan H, Boorgu DSSK, Goyal L, Weinstock M, Whelan R, Freiser ME, Corcoran TE, Jabbour N, Wang E, and Chi DH
- Subjects
- Aerosols, Cadaver, Endoscopy, Fluorescein, Humans, Models, Anatomic, Nebulizers and Vaporizers, Otolaryngology, Otorhinolaryngologic Surgical Procedures methods, Particle Size, SARS-CoV-2, COVID-19 transmission, Disease Transmission, Infectious, Fluorescent Dyes, Models, Biological, Nasopharynx surgery, Riboflavin
- Abstract
Objective: During the COVID-19 era, a reliable method for tracing aerosols and droplets generated during otolaryngology procedures is needed to accurately assess contamination risk and to develop mitigation measures. Prior studies have not investigated the reliability of different fluorescent tracers for the purpose of studying aerosols and small droplets. Objectives include (1) comparing vitamin B2, fluorescein, and a commercial fluorescent green dye in terms of particle dispersion pattern, suspension into aerosols and small droplets, and fluorescence in aerosolized form and (2) determining the utility of vitamin B2 as a fluorescent tracer coating the aerodigestive tract mucosa in otolaryngology contamination models., Methods: Vitamin B2, fluorescein, and a commercial fluorescent dye were aerosolized using a nebulizer and passed through the nasal cavity from the trachea in a retrograde-intubated cadaveric head. In another scenario, vitamin B2 was irrigated to coat the nasal cavity and nasopharyngeal mucosa of a cadaveric head for assessment of aerosol and droplet generation from endonasal drilling. A cascade impactor was used to collect aerosols and small droplets ≤14.1 µm based on average aerodynamic diameter, and the collection chambers were visualized under UV light., Results: When vitamin B2 was nebulized, aerosols ≤5.4 µm were generated and the collected particles were fluorescent. When fluorescein and the commercial water tracer dye were nebulized, aerosols ≤8.61 µm and ≤2.08 µm respectively were generated, but the collected aerosols did not appear visibly fluorescent. Endonasal drilling in the nasopharynx coated with vitamin B2 irrigation yielded aerosols ≤3.30 µm that were fluorescent under UV light., Conclusion: Vitamin B2's reliability as a fluorescent tracer when suspended in aerosols and small droplets ≤14.1 µm and known mucosal safety profile make it an ideal compound compared to fluorescein and commercial water-based fluorescent dyes for use as a safe fluorescent tracer in healthcare contamination models especially with human subjects.
- Published
- 2021
- Full Text
- View/download PDF
7. Plastic Surgery in the Time of COVID-19.
- Author
-
Chi D, Chen AD, Dorante MI, Lee BT, and Sacks JM
- Subjects
- Humans, Pandemics, SARS-CoV-2, COVID-19 epidemiology, Surgery, Plastic ethics
- Abstract
Background: The novel coronavirus disease 2019 (COVID-19) has swept the world in the last several months, causing massive disruption to existing social, economic, and health care systems. As with all medical fields, plastic and reconstructive surgery has been profoundly impacted across the entire spectrum of practice from academic medical centers to solo private practice. The decision to preserve vital life-saving equipment and cancel elective procedures to protect patients and medical staff has been extremely challenging on multiple levels. Frequent and inconsistent messaging disseminated by many voices on the national stage often conflicts and serves only to exacerbate an already difficult decision-making process., Methods: A survey of relevant COVID-19 literature is presented, and bioethical principles are utilized to generate guidelines for plastic surgeons in patient care through this pandemic., Results: A cohesive framework based upon core bioethical values is presented here to assist plastic surgeons in navigating this rapidly evolving global pandemic., Conclusion: Plastic surgeons around the world have been affected by COVID-19 and will adapt to continue serving their patients. The lessons learned in this present pandemic will undoubtedly prove useful in future challenges to come., Competing Interests: D.C., A.D.C., M.I.D., and B.T.L. have no commercial associations, financial interests, or conflicts of interest to disclose. J.M.S. is a cofounder of LifeSprout and a former consultant/speaker for Allergan; he receives unrestricted research funding from Vioptix. None of the authors have a financial interest in any of the products, drugs, or devices mentioned in this article. No funding was received for this work., (Thieme. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.